Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice

Shock

Volumn 33, Issue 6, 2010, Pages 646-654

  Hou, Lichao ^a   Xie, Keliang ^a,b   Qin, Mingzhe ^a,c   Peng, Daorong ^d   Ma, Shirong ^a   Shang, Lei ^e   Li, Nan ^a   Li, Shuzhi ^a   Ji, Genlin ^a   Lu, Yan ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Chinese PLA 254 Hospital   (China)

^d Departments of Clinical Laboratory   (China)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

100 oxygen treatment; Antioxidant enzyme; Inflammation; Inflammatory cytokine; Multiple organ dysfunction syndrome; Reactive oxygen species; Sepsis; Sterile

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; CATALASE; CYTOKINE; DIMETHYLTHIOUREA; GLUTATHIONE PEROXIDASE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; OXYGEN; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OXYGEN THERAPY; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SURVIVAL RATE; TISSUE OXYGENATION; UPREGULATION;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CYTOKINES; FREE RADICAL SCAVENGERS; HEART; INFLAMMATION; KIDNEY; LIVER; LUNG; MALE; MICE; MULTIPLE ORGAN FAILURE; MYOCARDIUM; OXYGEN; REACTIVE OXYGEN SPECIES; SEPSIS; THIOUREA; ZYMOSAN;

EID: 77952403835     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181c1b5d4     Document Type: Article

References (33)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
2. Pinsky MR: Pathophysiology of sepsis and multiple organ failure: pro-versus anti-inflammatory aspects. Contrib Nephrol 144:31-43, 2004.
3. Volman TJ, Hendriks T, Goris RJ: Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23:291-297, 2005.
4. Hou L, Xie K, Li N, Qin M, Lu Y, Ma S, Ji G, Xiong L: 100% oxygen inhalation protects against zymosan-induced sterile sepsis in mice: the roles of inflammatory cytokines and antioxidant enzymes. Shock 32(4):451-461, 2009.
5. Folz RJ, Abushamaa AM, Suliman HB: Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 103:1055-1066, 1999.
6. Altemeier WA, Sinclair SE: Hyperoxia in the intensive care unit: why more is not always better. Curr Opin Crit Care 13:73-78, 2007.
7. Liaw WJ, Chen TH, Lai ZZ, Chen SJ, Chen A, Tzao C, Wu JY, Wu CC: Effects of a membrane-permeable radical scavenger, tempol, on intraperitoneal sepsis-induced organ injury in rats. Shock 23:88-96, 2005.
8. Crimi E, Sica V, Slutsky AS, Zhang H, Williams-Ignarro S, Ignarro LJ, Napoli C: Role of oxidative stress in experimental sepsis and multisystem organ dysfunction. Free Radic Res 40:665-672, 2006.
9. Liu DD, Kao SJ, Chen HI: N-acetylcysteine attenuates acute lung injury induced by fat embolism. Crit Care Med 36:565-571, 2008.
10. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
11. Charvin D, Vanhoutte P, Pagès C, Borrelli E, Caboche J: Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation. Proc Natl Acad Sci USA 102:12218-12223, 2005.
12. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A: Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109:2357-2362, 2004.
13. Tsutsui H, Ide T, Hayashidani S, Suematsu N, Shiomi T, Wen J, Nakamura K-i, Ichikawa K, Utsumi H, Takeshita A: Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 104:134-136, 2001.
14. Barach AL: The therapeutic use of oxygen. JAMA 79:693-698, 1922.
15. O'Donohue WJ Jr, Plummer AL: Magnitude of usage and cost of home oxygen therapy in the United States. Chest 107:301-322, 1995.
16. Meier J, Kemming GI, Kisch-Wedel H, Blum J, Pape A, Habler OP: Hyperoxic ventilation reduces six-hour mortality after partial fluid resuscitation from hemorrhagic shock. Shock 22:240-247, 2004.
17. Bitterman H, Brod V, Weisz G, Kushnir D, Bitterman N: Effects of oxygen on regional hemodynamics in hemorrhagic shock. Am J Physiol 271: H203-H211, 1996.
18. Brod VI, Krausz MM, Hirsh M, Adir Y, Bitterman H: Hemodynamic effects of combined treatment with oxygen and hypertonic saline in hemorrhagic shock. Crit Care Med 34:2784-2791, 2006.
19. Sukhotnik I, Krausz MM, Brod V, Balan M, Turkieh A, Siplovich L, Bitterman H: Divergent effects of oxygen therapy in four models of uncontrolled hemorrhagic shock. Shock 18:277-284, 2002.
20. Barth E, Bassi G, Maybauer DM, Simon F, Gröger M, Oter S, Speit G, Nguyen CD, Hasel C, Möller P, et al.: Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med 36:495-503, 2008.
21. Knighton DR, Fiegel VD, Halverson T, Schneider S, Brown T, Wells CL: Oxygen as an antibiotic. The effect of inspired oxygen on bacterial clearance. Arch Surg 125:97-100, 1990.
22. Dröge W: Free radicals in the physiological control of cell function. Physiol Rev 82:47-95, 2002.
23. Bayir H: Reactive oxygen species. Crit Care Med 33:S498-S501, 2005.
24. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P: Caspase inhibition causes hyperacute tumor necrosis factorYinduced shock via oxi-dative stress and phospholipase A2. Nat Immunol 4:387-393, 2003. (Pubitemid 36432323)
25. Haddad JJ: Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun 296:847-856, 2002.
26. Ashare A, Powers LS, Butler NS, Doerschug KC, Monick MM, Hunninghake GW: Anti-inflammatory response is associated with mortality and severity ofinfection in sepsis. Am J Physiol Lung Cell Mol Physiol 288:633-640, 2005.
27. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
28. Hou LC, Qin MZ, Zheng LN, Lu Y, Wang Q, Peng DR, Yu XP, Xin YC, Ji GL, Xiong LZ: Severity of sepsis correlated with the elevation of serum high-mobility group box 1 in rats. Chin Med J 122: 449-454, 2009.
29. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, et al.: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570, 2000.
30. Shi C, Andersson R, Zhao X, Wang X: Potential role of reactive oxygen species in pancreatitis-associated multiple organ dysfunction. Pancreatology 5:492-500, 2005.
31. Yoshikawa T, Takano H, Takahashi S, Ichikawa H, Kondo M: Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circ Shock 42:53-58, 1994.
32. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Centorrino T, Lepore V, Terranova ML, Ciccolo A, Caputi AP, Thiemermann C: Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med 29:102-111, 2001.
33. Meissner F, Molawi K, Zychlinsky A: Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol 9:866-872, 2008.